carvedilol has been researched along with clopidogrel in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Archvadze, A; Gogorishvili, I; Kipiani, V; Kipshidze, N | 1 |
Parker, T | 1 |
Andjelkovic, N; Davidovic, G; Djurdjevic, P; Ignjatovic, V; Ignjatovic, VD; Iric-Cupic, V; Jovanovic, D; Miloradovic, V; Nesic, J; Pavlovic, S; Petrovic, N; Simic, I; Simovic, S; Smiljanic, Z; Stolic, R; Zdravkovic, V | 1 |
Degim, T; Ilbasmis-Tamer, S; Incecayir, T; Tirnaksiz, F | 1 |
Giacomini, T; Prato, G; Rossi, A; Severino, M; Verrina, E | 1 |
1 review(s) available for carvedilol and clopidogrel
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for carvedilol and clopidogrel
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Treatment of patients with cardiogenic shock in the setting of acute myocardial infarction. Case reports.
Topics: Aged; Angioplasty, Balloon; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carbazoles; Carvedilol; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Propanolamines; Shock, Cardiogenic; Stents; Ticlopidine; Vasodilator Agents | 2008 |
Case of the month. Idiopathic dilated cardiomyopathy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Angiography; Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Clopidogrel; Diuretics; Dyspnea; Echocardiography; Electrocardiography; Furosemide; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lisinopril; Male; Mineralocorticoid Receptor Antagonists; Platelet Aggregation Inhibitors; Potassium; Propanolamines; Pyrroles; Spironolactone; Ticlopidine | 2009 |
Influence of Different β-Blockers on Platelet Aggregation in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aspirin; Bisoprolol; Carbazoles; Carvedilol; Clopidogrel; Coronary Artery Disease; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Metoprolol; Middle Aged; Nebivolol; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Propanolamines; Prospective Studies; Ticlopidine; Treatment Outcome | 2016 |
Assessment of the potential drug-drug interaction between carvedilol and clopidogrel mediated through intestinal P-glycoprotein.
Topics: Adrenergic beta-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbazoles; Carvedilol; Clopidogrel; Drug Interactions; Intestinal Absorption; Intestine, Small; Male; Metoprolol; Perfusion; Permeability; Platelet Aggregation Inhibitors; Propanolamines; Rats; Rats, Wistar; Ticlopidine; Verapamil | 2016 |
Reversible cerebral vasoconstriction complicating cerebral atherosclerotic vascular disease in Schimke immuno-osseous dysplasia.
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Carvedilol; Child; Clopidogrel; Diagnosis, Differential; Female; Humans; Immunologic Deficiency Syndromes; Intracranial Arteriosclerosis; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Nephrotic Syndrome; Osteochondrodysplasias; Primary Immunodeficiency Diseases; Pulmonary Embolism; Vasoconstriction; Vasodilator Agents | 2018 |